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What is COPD? 
 Chronic obstructive pulmonary disease or 
COPD is a long-term inflammatory disease 
of the lungs, primarily caused by cigarette 
smoking. 
 It includes emphysema and chronic 
bronchitis and overlaps with asthma. 
 It results in increasing respiratory 
symptoms such as shortness of breath and 
in its severe stage can require long-term 
oxygen therapy. 
 It can have a profound impact on quality of 
life and often results in premature death. 
 
The problem 
 COPD is the fifth leading cause of death in 
the UK. 
 COPD costs the NHS ~£1 billion per year 
and is a major cause of hospital 
admissions. 
 Much of the disease burden remains 
undiagnosed with an estimated 2 million 
undiagnosed cases in the UK. 
 There is a national drive to identify 
patients with undiagnosed COPD so that 
they get better access to the healthcare 
they need. 
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Our solution 
 Developed a risk prediction model that can 
be used by general practitioners to help 
identify patients with undiagnosed COPD.  
 Compared risk factors routinely recorded in 
primary care between 9397 patients with 
COPD and 17829 patients without COPD. 
 We used a statistical method called 
multiple logistic regression to develop a 
risk prediction model that incorporates risk 
factors significantly associated with COPD 
(see figure- the numbers indicate the size 
of the association between the risk factor 
and COPD). 
 We tested the accuracy of the model on a 
separate group of patients consisting of 
4615 with COPD and 8756 without COPD. 
 Accuracy of the model was assessed using 
a statistic called the area under the 
receiver operator characteristic curve (or 
AUC). An AUC of 1 indicates perfect 
accuracy while an AUC of 0.5 indicates an 
indiscriminate model. 
 Our model had an AUC of 0.87 which 
demonstrates a promising ability to identify 
patients with undiagnosed COPD. 
 Our model could detect up to 80% of 
patients with undiagnosed COPD. 
 We aim to further develop and validate this 
model using data from a large randomised 
controlled trial (Birmingham Lung 
Improvement Studies, TargetCOPD) 
 
Application 
 Simple scoring 
system used by a 
clinician with or 
without the aid of 
software.  
 Incorporation into 
primary care 
information 
systems to estimate 
COPD risk scores 
for an entire 
population. 
 Allow clinicians in 
primary care to 
identify patients at 
high risk of COPD 
who might benefit 
from further clinical 
assessment and 
treatment. 
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